Figure 2: Cross-section view of fetal thorax at level of four chamber view. Note the bright, shaped lesion in the area of the mitral valve.
Spontaneous labor occurred at 39 weeks gestational age. There were no intrapartum fetal heart rate abnormalities noted on continuous monitoring. A secondary arrest of labor occurred and a primary cesarean section was performed yielding a 3073g male infant with an Apgar score of 3 and 9 at one and 5 minutes, respectively.
Table 1: Fetal measurements (in mm.).
Age
|
Biparietal diameter
|
Tumor perimeter
|
Heart perimeter di-fdi-fdi-fdi-fdi-fdi-fdi-fdi-f>
|
Chest perimeter
|
Diastolic biventricular diameter
|
Tumor/ heart ratio
|
Hear/ chest ratio
|
27
|
68
|
143
|
179
|
264
|
35
|
0.799
|
0.678
|
30
|
75
|
153
|
211
|
276
|
50
|
0.725
|
0.764
|
35
|
85
|
166
|
233
|
305
|
54
|
0.712
|
0.764
|
Postnatal course
The neonate exhibited mild respiratory distress requiring temporary oxygen therapy in the form of a head hood. Physical exam revealed a hyperdynamic precordium with both systolic and diastolic murmurs. Cardiomegaly was evident on chest X-ray and the EKG revealed a normal sinus rhythm with a shortened PR interval and intraventricular conduction delay consistent with Wolf-Parkinson-White syndrome. Head CT-scan and EEG were normal. Echocardiography revealed a multilobular echo dense mass involving the left ventricle and atrium along the ventricular septum, mild mitral stenosis, moderate mitral regurgitation, a patent foramen ovale with left to right shunting and a patent ductus arteriosus. The ductus arteriosus closed spontaneously. The infants cardiovascular and respiratory status remained stable, with no evidence of congestive heart failure, and he was subsequently discharged home. No surgical intervention was required and subsequent echocardiograms have documented a decrease in the size of the tumor. The infant remains asymptomatic at this time. Detailed physical and radiologic examination of both mother and infant failed to show any evidence of tuberous sclerosis.
Discussion
Primary cardiac neoplasms are rare constituting only a small fraction of the incidence of congenital heart disease occurring in the general population. Cardiac tumors are estimated to occur in 1-2:10,000 patients and over 90% of these are benign1-3. Rhabdomyomas are the most common benign cardiac neoplasms occurring in the fetus and neonate, with most identified within the first year of life4.
Pathogenesis
The etiology is unknown. A rhabdomyoma resembles a hamartoma derived from embryonal myoblasts in which there is an abnormal proliferation of tissue yielding single or multiple solid circumscribed, unencapsulated tumors of variable size. They may arise anywhere in the myocardium, most commonly the ventricle, but not from a valve, and may project into a cardiac chamber. Grossly the appear as yellow-tan solid, circumscribed, unencapsulated tumors. Microscopically, the characteristic spider cell is seen which is a large clear cell with cytoplasmic strands composed of glycogen extending to the plasma membrane.
Associated anomalies
There is a very strong association between cardiac rhabdomyomas and tuberous sclerosis, occurring in 50-86% of patients with cardiac rhabdomyomas18,19. Tuberous sclerosis is an autosomal dominant disorder with variable expressivity and high penetrance20. However, between 50 and 80 percent of cases are new mutations13. The gene for tuberous sclerosis has been localized on chromosome 9 (9q34) 21. Clinical manifestations of tuberous sclerosis include skin lesions (depigmented marks, adenoma sebaceum, shagreen patches), cerebral abnormalities (periventricular calcifications or nodules, seizures, cerebral atrophy) and retinal phakomata. Renal angiomyolipomas and hamartomas are very common in patients with tuberous sclerosis but usually develop later in life and progress slowly. Of the dermatologic lesions, hypomelanotic macules are usually present at birth, are diffuse and do not follow linear patterns. Skin biopsy or Woods light examination of these lesions establishes the diagnosis. There is no association of cardiac rhabdomyoma with any genetic or familial disorders with the exception of tuberous sclerosis.
Differential diagnosis
The differential diagnosis of fetal cardiac tumors includes, in order of descending frequency, rhabdomyoma, teratoma, fibroma, myxoma and hemangioma. Sonographically, these tumors appear as single or multiple, homogeneous, echogenic masses within the myocardium. Teratomas may appear as complex masses, typically involve the pericardium and are usually associated with pericardial effusions. Fibromas tend to be discrete single lesions usually found in the left ventricular wall. Myxomas are very rare lesions, usually involving the left atrium, and appear similar to rhabdomyomas.
Prognosis
The prognosis depends on the number, size and location of the tumors as well as the presence or absence of associated anomalies. Intracavitary growth of the tumors may cause disruption of intracardiac blood flow leading to congestive heart failure and hydrops. Cardiac dysrhythmias, caused by compression of the conducting system, are also frequently identified. Rhabdomyomas grow slowly in utero but tend to regress spontaneously after birth14. Fenogiol et al. has shown that rhabdomyomas cells lose there ability to divide over time which may account for the spontaneous regression of these tumors noted clinically22.
Management
When the diagnosis of a cardiac tumor is made prior to fetal viability, pregnancy termination may be offered. Serial ultrasonic evaluations should be performed to identify signs of congestive heart failure or dysrhythmia. Standard obstetrical management is appropriate for uncomplicated cases. Delivery should take place in a tertiary care center were a pediatric cardiologist is available. Conservative neonatal management is indicated in the asymptomatic patient with surgery reserved for those with hemodynamic compromise.
When the fetal rhabdomyoma is diagnosed, careful evaluation of other fetal structures should be performed looking for signs of tuberous sclerosis. Particular attention should be directed toward the central nervous system and kidneys. A detailed family history, particularly of mental retardation and epilepsy, should be obtained and first degree relatives should undergo a physical examination to identify clinical evidence of tuberous sclerosis. In the absence of a family history, a fetal cardiac rhabdomyoma should imply the diagnosis of tuberous sclerosis, whether the disease is clinically manifest or not23.
References
1. McAllister H Jr. Primary tumors of the heart and pericardium. Pathol Annu 14:325-30, 1979.
2. Smaltz A, Apitz J. Primary heart tumors in infancy and childhood (report of 4 cases and review of literature. Cardiology 67:12-6, 1981.
3. Hammer LH, Kaye MF, Weingold AB. Difficulty of fetal monitoring in a fetus with intracardiac tumors. Obstet Gynecol 73:447-81, 1989.
4. Van der Hauwaert LG. Cardiac tumors in infancy and childhood. Br Heart J 33:125-32, 1971.
5. Gava G, Buoso G, Beltrame GL, Memo L, Visentin S, Cavarzerani A. Cardiac rhabdomyoma as a marker for the prenatal detection of tuberous sclerosis. Case report. Br J Obstet Gynecol 97:1154-7, 1990.
6. Giacoia GP. Fetal rhabdomyoma: A prenatal echocardiographic marker of tuberous sclerosis. Am J Perinatal 9:111-4, 1992.
7.Smith HC, Watson GH, Patel RG, Super M. Cardiac rhabdomyoma in tuberous sclerosis: their course and diagnostic value. Arch Disease in Childhood 64:196-200, 1989.
8. Journel H, Roussey M, Plais MH, Milon J, Almange C, Le Marec B. Prenatal diagnosis of familial tuberous sclerosis following detection of cardiac rhabdomyoma by ultrasound. Prenat Diagn 6:283-9, 1986.
9. Green KW, Bors‑Koefoed R, Pollack P, Weinbaum PJ. Antepartum diagnosis and management of multiple fetal cardiac tumors. J Ultrasound Med 10:697-9, 1991.
10. Soltan MH, Keohane C. Hydrops fetalis due cla cla cla cla cla cla cla claoma. Br J Obstet Gynecol 88:771-3, 1981.
11. Calhoun BC, Watson PT, Hegge F. Ultrasound diagnosis of an obstructive cardiac rhabdomyoma with severe hydrops and hypoplastic lungs: A case report. J Reprod Med 36:317-9, 1991.
12. Bass JL, Breningstall GN, Swaiman KF. Echocardiographic incidence of cardiac rhabdomyoma in tuberous sclerosis. Am J Cardiol 55:1379-82, 1985.
13. Chitayat D, McGillivray BC, Diamant S, Wittmann BK, Sandor GGS. Role of prenatal detection of cardiac tumours in the diagnosis of tuberous sclerosis‑Report of two cases. Prenat Diagn 8:577-84, 1988.
14. Alkalay A, Ferry DA, Lin B, Fink B, Promerance JJ. Spontaneous regression of cardiac tumor rhabdomyoma in tuberous sclerosis. Clin Pediatr 26:532-5, 1987.
15. Hoffman JI, Christianson R. Congenital heart disease in a cohort of 19,502 births with long-term follow‑up. Am J Cardiol 42:641-7, 1978.
16. Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births. Incidence and natural history. Circulation 43:323-32, 1971.
17. DeVore G, Siassi B, Platt LD. Fetal echocardiography IV. M‑mode assessment of ventricular size and contractility during the second and third trimesters of pregnancy in the normal fetus. Am J Obstet Gynecol 150:981-8, 1984.
18. Corno A, de Simone G, Catena G. Cardiac rhabdomyoma: Surgical treatment in the neonate. J Thorac Surg 87:725-31, 1984.
19. Dennis MA, Appareti K, Manco-Johnson ML. The echocardiographic diagnosis of multiple fetal cardiac tumors. J Ultrasound Med 4:327-9, 1985.
20. Hunt A, Lindenbaum RH. Tuberous sclerosis: a new estimate of prevalence within the Oxford region. J Med Genet 21:272-77, 1984.
21. Smith M, Simpson NE. Report of the committee on the genetic constitution of chromosomes 9 and 10. Cytogent Cell Genet 49:71-8, 1988.
22. Fenogilo JJ, McAllister HA, Ferrans VJ. Cardiac rhabdomyoma: a clinicopathologic and electron microscopy study. Am J Cardiol 38:241-51, 1976.
23. Davies MJ. Tumors of the heart and pericardium. In: Pomerance A, Davies MJ, eds. The pathology of the heart. London: Blackwell 423-40, 1975.